2024
Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective
Elkeraie A, Al-Ghamdi S, Abu-Alfa A, Alotaibi T, AlSaedi A, AlSuwaida A, Arici M, Ecder T, Ghnaimat M, Hafez M, Hassan M, Sqalli T. Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective. International Journal Of Nephrology And Renovascular Disease 2024, 17: 1-16. PMID: 38196830, PMCID: PMC10771977, DOI: 10.2147/ijnrd.s430532.Peer-Reviewed Original ResearchChronic kidney diseaseSodium-glucose cotransporter 2 inhibitorsCotransporter 2 inhibitorsDiabetes mellitusKidney diseaseType 2 diabetes mellitusMajor public health concernAldosterone system inhibitorsBetter clinical outcomesCause of deathPublic health concernNephrology referralCKD managementClinical outcomesSystem inhibitorsCardioprotective propertiesEarly initiationTreatment pathwaysConsensus recommendationsHigh riskPatientsBetter careHealth concernEarly detectionHypertension
2022
Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
Abu-Alfa A, Atallah P, Azar S, Dagher E, Echtay A, El-Amm M, Hazkial H, Kassab R, Medlej R, Mohamad M. Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications. Diabetes Therapy 2022, 14: 11-28. PMID: 36517708, PMCID: PMC9880119, DOI: 10.1007/s13300-022-01340-x.Peer-Reviewed Original ResearchType 2 diabetesGlycemic statusGlucagon-like peptide-1 receptor agonistsSodium-glucose cotransporter 2 inhibitorsMajor randomized clinical trialsPeptide-1 receptor agonistsCardio-renal benefitsCardio-renal complicationsMultifactorial risk assessmentCotransporter 2 inhibitorsGlucose-lowering agentsIndividualized management planDisease-modifying drugsPrevalence of T2DRandomized clinical trialsPatient's glycemic statusFavorable health outcomesMedical societiesInternational medical societiesScientific Medical SocietiesGlobal health problemAppropriate pharmacological therapyPatient-centered approachLocal medical practiceSuboptimal screening